Latest Institutional Purchases of Sab Biotherapeutics, Inc. (SABS)
This list provides information on the latest institutional transactions involving Sab Biotherapeutics, Inc. (SABS) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Penserra Capital Management LLC
Orinda, CA |
BUY
|
- |
2.68K+ 71.99% |
$2.98K - $9.28K
|
6.41K
$19.9K
|
|
|
Aug 15, 2022
Q2 2022
|
ETF Managers Group, LLC
Summit, NJ |
BUY
|
- |
394+ 2.99% |
$437 - $1.36K
|
13.6K
$42.1K
|
|
| Q4 2021 | |||||||
|
Feb 08, 2022
Q4 2021
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
44.5KNew |
$325K - $500K
|
44.5K
$138K
|
|
|
Feb 03, 2022
Q4 2021
|
Daiwa Securities Group Inc.
Tokyo, M0 |
BUY
|
- |
127New |
$927 - $1.43K
|
127
$394
|
|